ANTIBODY FOR CELIAC DISEASE - ANVISA Registration 80213250668

Access comprehensive regulatory information for ANTIBODY FOR CELIAC DISEASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80213250668 and manufactured by BIOSYSTEMS S/A. The registration is held by PHAREBEE DIAGNOSTICOS COMERCIO IMPORTACAO E EXPORTACAO DE PRODUTOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, EUROIMMUN AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80213250668
Registration Details
ANVISA Registration Number: 80213250668
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

ANTICORPOS ANTI-tTRANSGLUTAMINASE IgA (ANTI-tTG IgA)
Risk Class II

Registration Details

80213250668

25351156130201708

64128853000196

Company Information

BIOSYSTEMS S/A
Spain
PT: ESPANHA

Dates and Status

Apr 24, 2017

VIGENTE

09/18/2025 19:00:01